- Home
- ETON vs YSG Comparison
ETON vs YSG Comparison
Compare ETON & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- YSG
- Stock Information
- Founded
- ETON 2017
- YSG 2016
- Country
- ETON United States
- YSG China
- Employees
- ETON N/A
- YSG N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- YSG Package Goods/Cosmetics
- Sector
- ETON Health Care
- YSG Consumer Discretionary
- Exchange
- ETON Nasdaq
- YSG Nasdaq
- Market Cap
- ETON 329.8M
- YSG 306.5M
- IPO Year
- ETON 2018
- YSG 2020
- Fundamental
- Price
- ETON $14.51
- YSG $3.88
- Analyst Decision
- ETON Strong Buy
- YSG
- Analyst Count
- ETON 3
- YSG 0
- Target Price
- ETON $24.00
- YSG N/A
- AVG Volume (30 Days)
- ETON 330.6K
- YSG 79.3K
- Earning Date
- ETON 03-13-2025
- YSG 02-25-2025
- Dividend Yield
- ETON N/A
- YSG N/A
- EPS Growth
- ETON N/A
- YSG N/A
- EPS
- ETON N/A
- YSG N/A
- Revenue
- ETON $34,677,000.00
- YSG $472,960,724.00
- Revenue This Year
- ETON $22.19
- YSG $2.29
- Revenue Next Year
- ETON $110.87
- YSG $5.70
- P/E Ratio
- ETON N/A
- YSG N/A
- Revenue Growth
- ETON 5.64
- YSG N/A
- 52 Week Low
- ETON $3.03
- YSG $1.99
- 52 Week High
- ETON $18.41
- YSG $5.22
- Technical
- Relative Strength Index (RSI)
- ETON 41.72
- YSG 61.52
- Support Level
- ETON $14.18
- YSG $3.12
- Resistance Level
- ETON $17.13
- YSG $4.27
- Average True Range (ATR)
- ETON 1.03
- YSG 0.22
- MACD
- ETON -0.50
- YSG 0.11
- Stochastic Oscillator
- ETON 7.80
- YSG 66.09
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The Group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.